Out-of-pocket insulin spending before and after the Inflation Reduction Act across demographic subgroups
{{output}}
Introduction: The Inflation Reduction Act (IRA) capped out-of-pocket (OOP) insulin spending at $35 for Medicare Part D beneficiaries in 2023. Studies have shown lower per-prescription insulin spending after the IRA but less is kn... ...
